Simultaneous response of cutaneous and lung squamous cell carcinoma with cemiplimab

Dermatol Ther. 2020 Nov;33(6):e13951. doi: 10.1111/dth.13951. Epub 2020 Jul 16.

Authors

Gabriela Fortes Escobar¹, Florence Granel-Brocard¹, Jean-Luc Schmutz¹, Pierre Cervantes², Sinan Ben Mahmoud³, Anne-Claire Bursztejn¹

Affiliations

¹ Department of Dermatology, Center Hospitalier Universitaire de Nancy, Nancy, France.
² Department of Pulmonology, Hospital Robert Schuman, Metz, France.
³ Department of Nuclear Medicine, Center Hospitalier Régional Metz-Thionville, Metz, France.

PMID: 32614130
DOI: 10.1111/dth.13951

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Carcinoma, Squamous Cell*
Humans
Lung
Skin Neoplasms*

Substances

Antibodies, Monoclonal, Humanized
cemiplimab